Abstract
Serial intravascular ultrasound studies were performed to evaluate the effect of pravastatin on coronary atherosclerotic plaque. Administration of pravastatin reduced serum lipid levels and progression of coronary artery atherosclerotic plaque.
Publication types
-
Clinical Trial
-
Randomized Controlled Trial
MeSH terms
-
Aged
-
Anticholesteremic Agents / therapeutic use*
-
Constriction, Pathologic
-
Coronary Artery Disease / blood
-
Coronary Artery Disease / diagnostic imaging*
-
Coronary Artery Disease / drug therapy*
-
Disease Progression
-
Humans
-
Male
-
Middle Aged
-
Pravastatin / therapeutic use*
-
Treatment Outcome
-
Ultrasonography, Interventional*
Substances
-
Anticholesteremic Agents
-
Pravastatin